MX360034B - Determinacion no invasiva del metiloma fetal o de tumor de plasma. - Google Patents

Determinacion no invasiva del metiloma fetal o de tumor de plasma.

Info

Publication number
MX360034B
MX360034B MX2015003571A MX2015003571A MX360034B MX 360034 B MX360034 B MX 360034B MX 2015003571 A MX2015003571 A MX 2015003571A MX 2015003571 A MX2015003571 A MX 2015003571A MX 360034 B MX360034 B MX 360034B
Authority
MX
Mexico
Prior art keywords
methylation
fetal
tumor
dna
fetus
Prior art date
Application number
MX2015003571A
Other languages
English (en)
Spanish (es)
Other versions
MX2015003571A (es
Inventor
Yuk-Ming Dennis Lo
Wai Kwun Rossa Chiu
Peiyong Jiang
Kwan Chee Chan
Miu Fan Lun
Wai Man Chan
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50340462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX360034(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/842,209 external-priority patent/US9732390B2/en
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Publication of MX2015003571A publication Critical patent/MX2015003571A/es
Publication of MX360034B publication Critical patent/MX360034B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
MX2015003571A 2012-09-20 2013-09-20 Determinacion no invasiva del metiloma fetal o de tumor de plasma. MX360034B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261703512P 2012-09-20 2012-09-20
US13/842,209 US9732390B2 (en) 2012-09-20 2013-03-15 Non-invasive determination of methylome of fetus or tumor from plasma
US201361830571P 2013-06-03 2013-06-03
PCT/AU2013/001088 WO2014043763A1 (en) 2012-09-20 2013-09-20 Non-invasive determination of methylome of fetus or tumor from plasma

Publications (2)

Publication Number Publication Date
MX2015003571A MX2015003571A (es) 2015-06-22
MX360034B true MX360034B (es) 2018-10-19

Family

ID=50340462

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015003571A MX360034B (es) 2012-09-20 2013-09-20 Determinacion no invasiva del metiloma fetal o de tumor de plasma.

Country Status (28)

Country Link
EP (6) EP3536807B1 (enExample)
JP (6) JP6317354B2 (enExample)
KR (5) KR102307424B1 (enExample)
CN (2) CN117757932A (enExample)
AU (5) AU2013317708C1 (enExample)
BR (3) BR122021021823B1 (enExample)
CA (2) CA2884066C (enExample)
CY (1) CY1124139T1 (enExample)
DK (4) DK4056712T3 (enExample)
EA (1) EA201500327A1 (enExample)
ES (5) ES3060911T3 (enExample)
FI (2) FI3536807T3 (enExample)
HR (3) HRP20240210T1 (enExample)
HU (3) HUE053822T2 (enExample)
IL (4) IL313451A (enExample)
LT (2) LT3354747T (enExample)
MX (1) MX360034B (enExample)
MY (2) MY187444A (enExample)
NZ (2) NZ717423A (enExample)
PH (2) PH12022552061A1 (enExample)
PL (5) PL4056712T3 (enExample)
PT (4) PT4056712T (enExample)
SG (2) SG11201501927VA (enExample)
SI (1) SI4056712T1 (enExample)
SM (1) SMT202100256T1 (enExample)
TW (6) TWI784258B (enExample)
WO (1) WO2014043763A1 (enExample)
ZA (1) ZA201501772B (enExample)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101153336B (zh) 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
HUE053822T2 (hu) 2012-09-20 2021-07-28 Univ Hong Kong Chinese Nem invazív módszer daganat metilom meghatározása plazmából
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2685893T3 (es) * 2013-07-30 2018-10-15 Bgi Genomics Co., Limited Método para determinar la composición de ácidos nucleicos de una mezcla de ácidos nucleicos
US10174375B2 (en) * 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
WO2015126840A1 (en) * 2014-02-18 2015-08-27 Bionano Genomics, Inc. Improved methods of determining nucleic acid structural information
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
RU2717641C2 (ru) * 2014-04-21 2020-03-24 Натера, Инк. Обнаружение мутаций и плоидности в хромосомных сегментах
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
US10801067B2 (en) 2014-05-09 2020-10-13 Eurofins Lifecodexx Gmbh Detection of DNA that originates from a specific cell-type and related methods
TWI758011B (zh) 2014-07-18 2022-03-11 香港中文大學 Dna混合物中之組織甲基化模式分析
WO2016010401A1 (ko) * 2014-07-18 2016-01-21 에스케이텔레콘 주식회사 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법
CN107002122B (zh) 2014-07-25 2023-09-19 华盛顿大学 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法
WO2016109452A1 (en) 2014-12-31 2016-07-07 Guardant Health , Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
DK3256605T3 (da) * 2015-02-10 2022-03-14 Univ Hong Kong Chinese Påvisning af mutationer til cancerscreening og føtal analyse
WO2017012544A1 (en) * 2015-07-20 2017-01-26 The Chinese University Of Hong Kong Methylation pattern analysis of haplotypes in tissues in dna mixture
US10453556B2 (en) * 2015-07-23 2019-10-22 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free DNA
US11319586B2 (en) 2015-08-12 2022-05-03 The Chinese University Of Hong Kong Single-molecule sequencing of plasma DNA
MY199897A (en) 2015-09-22 2023-11-28 Univ Hong Kong Chinese Accurate quantification of fetal dna fraction by shallow-depth sequencing of maternal plasma dna
US10260088B2 (en) * 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
EP4180532A1 (en) * 2015-11-09 2023-05-17 Roche Molecular Systems, Inc. Methods for determining the origin of dna molecules
HUE050491T2 (hu) 2015-11-10 2020-12-28 Eurofins Lifecodexx Gmbh Magzati kromoszomális aneuploidiák kimutatása olyan DNS régiókat alkalmazva, amelyek különbözõképpen vannak metilezve a magzat és a terhes nõstény között
CA3168463A1 (en) * 2015-12-17 2017-06-22 Illumina, Inc. Distinguishing methylation levels in complex biological samples
EP4779643A2 (en) * 2016-02-02 2026-07-22 Guardant Health, Inc. Cancer evolution detection and diagnostic
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
WO2017181146A1 (en) * 2016-04-14 2017-10-19 Guardant Health, Inc. Methods for early detection of cancer
US11078475B2 (en) 2016-05-03 2021-08-03 Sinai Health System Methods of capturing cell-free methylated DNA and uses of same
CA3023335A1 (en) * 2016-05-04 2017-11-30 Queen's University At Kingston Cell-free detection of methylated tumour dna
CN115161390B (zh) 2016-05-30 2025-12-05 香港中文大学 使用血液中的无细胞dna检测血液病症
WO2017218908A2 (en) * 2016-06-16 2017-12-21 The Johns Hopkins University Methods and system for epigenetic analysis
CN107779485B (zh) * 2016-08-24 2022-03-18 中国科学院分子细胞科学卓越创新中心 Cmd1酶催化的5-甲基胞嘧啶核酸的新修饰及其应用
EP4209598A1 (en) 2016-10-19 2023-07-12 The Chinese University of Hong Kong Gestational age assessment by methylation and size profiling of maternal plasma dna
TWI797095B (zh) 2016-10-24 2023-04-01 美商格瑞爾有限責任公司 腫瘤檢測之方法及系統
IL266347B2 (en) * 2016-11-30 2025-01-01 Univ Hong Kong Chinese Analysis of cell-free DNA in urine and other samples
US20190309374A1 (en) * 2016-12-13 2019-10-10 Bellwether Bio, Inc. Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample
MX2019008320A (es) * 2017-01-11 2019-09-09 Quest Diagnostics Invest Llc Metodo para la deteccion prenatal no invasiva de aneuploidia.
ES2981092T3 (es) * 2017-01-24 2024-10-07 Bgi Genomics Co Ltd Procedimiento para determinar la proporción de ácidos nucleicos acelulares procedentes de una fuente predeterminada en una muestra biológica
WO2018137685A1 (en) 2017-01-25 2018-08-02 The Chinese University Of Hong Kong Diagnostic applications using nucleic acid fragments
CN107247873B (zh) * 2017-03-29 2020-04-14 电子科技大学 一种差异甲基化位点识别方法
CN111417731A (zh) * 2017-05-12 2020-07-14 哈佛学院校长同事会 通用早期癌症诊断
US12227737B2 (en) 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
CA3069668A1 (en) * 2017-07-12 2019-01-17 Ande Corporation Pattern recognition system
KR102628878B1 (ko) * 2017-07-12 2024-01-23 유니버시티 헬스 네트워크 메틸롬 분석을 이용한 암 검출 및 분류
WO2019020057A1 (en) 2017-07-26 2019-01-31 The Chinese University Of Hong Kong ENHANCING CANCER SCREENING WITH ACELLULAR VIRAL NUCLEIC ACIDS
US20200263170A1 (en) 2017-09-14 2020-08-20 Grail, Inc. Methods for preparing a sequencing library from single-stranded dna
WO2019067973A1 (en) 2017-09-28 2019-04-04 Grail, Inc. ENRICHMENT OF SHORT NUCLEIC ACID FRAGMENTS IN THE PREPARATION OF SEQUENCING LIBRARIES
US11168356B2 (en) 2017-11-02 2021-11-09 The Chinese University Of Hong Kong Using nucleic acid size range for noninvasive cancer detection
CN111989407B (zh) 2018-03-13 2024-10-29 格里尔公司 异常的片段检测及分类
AU2019233897B2 (en) * 2018-03-15 2024-10-24 Grail, Inc. Tissue-specific methylation marker
CA3302676A1 (en) 2018-04-02 2026-05-13 Grail, Inc. Methylation markers and targeted methylation probe panels
WO2019200410A1 (en) * 2018-04-13 2019-10-17 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples
CN121137125A (zh) * 2018-04-16 2025-12-16 格里尔公司 用于确定在无细胞核酸中的肿瘤分数的系统及方法
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
US11932899B2 (en) * 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
CN109448789A (zh) * 2018-09-17 2019-03-08 上海派森诺生物科技股份有限公司 一种基于perl语言的种群特异SNP位点的自动化分析方法
EP3856903A4 (en) 2018-09-27 2022-07-27 Grail, LLC METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL
CN109295230A (zh) * 2018-10-24 2019-02-01 福建翊善生物科技有限公司 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法
AU2019384154B2 (en) 2018-11-21 2025-11-20 Agilent Technologies, Inc. Methods for targeted nucleic acid library formation
CN113366122B (zh) * 2018-12-19 2024-01-12 香港中文大学 游离dna末端特征
EP3899953A1 (en) 2018-12-21 2021-10-27 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
WO2020163410A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
ES2994567T3 (en) 2019-02-05 2025-01-27 Grail Inc Detecting cancer, cancer tissue of origin, and/or a cancer cell type
TWI874374B (zh) 2019-03-25 2025-03-01 香港中文大學 確定循環核酸之線性及環狀形式
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
AU2020268885B2 (en) * 2019-05-03 2026-06-11 Cornell University Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes
KR102452413B1 (ko) * 2019-08-19 2022-10-11 주식회사 지씨지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
JP7859967B2 (ja) * 2019-08-19 2026-05-15 グリーン クロス ゲノム コーポレーション 核酸断片間距離情報を用いた染色体異常検出方法
EP3795685A1 (en) 2019-09-20 2021-03-24 Sophia Genetics S.A. Methods for dna library generation to facilitate the detection and reporting of low frequency variants
GB201915469D0 (en) 2019-10-24 2019-12-11 Univ London Cancer detection methods
WO2021108654A1 (en) * 2019-11-27 2021-06-03 Grail, Inc. Systems and methods for evaluating longitudinal biological feature data
CN115103909A (zh) 2020-01-31 2022-09-23 艾维达生物医学公司 用于靶向核酸捕获的系统和方法
CN115398007A (zh) * 2020-02-10 2022-11-25 帕洛根公司 纳米孔装置和使用其检测和分类带电粒子的方法
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
WO2021174072A1 (en) * 2020-02-28 2021-09-02 Grail, Inc. Identifying methylation patterns that discriminate or indicate a cancer condition
CN112662764A (zh) * 2020-03-17 2021-04-16 博尔诚(北京)科技有限公司 一种检测11种癌症的探针组合物
US12592321B2 (en) 2020-06-19 2026-03-31 University Health Network Cancer detection and classification using methylome analysis
RU2738675C1 (ru) * 2020-07-28 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов
AU2021384324A1 (en) * 2020-11-19 2023-06-22 Nucleix Ltd. Detecting methylation changes in dna samples using restriction enzymes and high throughput sequencing
WO2022133315A1 (en) * 2020-12-17 2022-06-23 President And Fellows Of Harvard College Methods of cancer detection using extraembryonically methylated cpg islands
CN112813148A (zh) * 2021-02-02 2021-05-18 博淼生物科技(北京)有限公司 飞行时间质谱检测5-羟甲基胞嘧啶的方法
CN118302816A (zh) * 2021-09-28 2024-07-05 行动基因(智财)有限公司 甲基化生物标记选择装置及方法
KR20230059423A (ko) * 2021-10-26 2023-05-03 주식회사 지씨지놈 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법
CN118215743A (zh) * 2021-11-04 2024-06-18 通用诊断股份公司 用于制备用于基因测序的生物样品的系统和方法
GB2636509B (en) 2022-02-07 2026-02-18 Centre For Novostics Fragmentation for measuring methylation and disease
US20240150840A1 (en) * 2022-02-22 2024-05-09 Flagship Pioneering Innovations Vi, Llc Intra-individual analysis for presence of health conditions
CN115064211B (zh) * 2022-08-15 2023-01-24 臻和(北京)生物科技有限公司 一种基于全基因组甲基化测序的ctDNA预测方法及装置
CN115612723B (zh) * 2022-09-26 2023-07-14 广州女娲生命科技有限公司 植入前胚胎的筛选方法
EP4623107A4 (en) * 2022-11-23 2026-03-11 Found Medicine Inc CUSTOMIZED METHYLATION BIOMARKER MONITORING SYSTEMS AND METHODS FOR DISEASE DETECTION
WO2024203348A1 (ja) * 2023-03-31 2024-10-03 ソニーグループ株式会社 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法
CN118737268A (zh) * 2023-05-04 2024-10-01 杭州圣庭医疗科技有限公司 一种鉴定肿瘤组织来源的试剂盒的数据分析方法
CN117025753A (zh) * 2023-08-15 2023-11-10 广州女娲生命科技有限公司 检测染色体变异的方法和装置
CN117079822B (zh) * 2023-10-17 2024-01-02 北京大学第三医院(北京大学第三临床医学院) 一种妊娠早中期四因子预测胎儿脑损伤的系统

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927028B2 (en) 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
DK1342794T3 (da) † 2002-03-05 2006-04-24 Epigenomics Ag Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
EP1570081A4 (en) * 2002-11-19 2006-05-31 Amgen Inc AMPLIFIED GENES INVOLVED IN CANCER
US20060183128A1 (en) † 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
EP2380993B1 (en) 2004-03-08 2015-12-23 Rubicon Genomics, Inc. Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
WO2006128192A2 (en) 2005-05-27 2006-11-30 John Wayne Cancer Institute Use of free circulating dna for diagnosis, prognosis, and treatment of cancer
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
US7754428B2 (en) * 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
CN101153336B (zh) * 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
WO2008155549A2 (en) 2007-06-19 2008-12-24 Oncomethylome Sciences Sa Improved urine sample collecting and processing
US12054776B2 (en) 2007-07-23 2024-08-06 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
JP4347372B2 (ja) 2007-08-10 2009-10-21 トヨタ自動車株式会社 静電塗装装置
US20110028333A1 (en) * 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8563242B2 (en) * 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
WO2011038507A1 (en) * 2009-10-02 2011-04-07 Centre For Addiction And Mental Health Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids
LT3241914T (lt) * 2009-11-05 2019-04-25 The Chinese University Of Hong Kong Vaisiaus genomo analizė iš motinos biologinio mėginio
CA2780016C (en) 2009-11-06 2017-09-19 The Chinese University Of Hong Kong Size-based genomic analysis
AU2011207544A1 (en) * 2010-01-19 2012-09-06 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing
EP2529032B1 (en) † 2010-01-26 2017-01-25 Nipd Genetics Ltd Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
JP6073217B2 (ja) † 2010-04-29 2017-02-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ゲノムモデルに関するデータ統合を用いたパスウェイ認識アルゴリズム(paradigm)
GB201007944D0 (en) * 2010-05-12 2010-06-30 Univ Aberystwyth Methods
ES2581594T3 (es) 2010-05-25 2016-09-06 The Johns Hopkins University Composiciones y métodos para detectar una neoplasia
SG10201505723UA (en) * 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
EP2596127A2 (en) * 2010-07-23 2013-05-29 Esoterix Genetic Laboratories, LLC Identification of differentially represented fetal or maternal genomic regions and uses thereof
WO2012031329A1 (en) 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
KR102040307B1 (ko) † 2010-11-30 2019-11-27 더 차이니즈 유니버시티 오브 홍콩 암과 연관된 유전적 또는 분자적 이상들의 검출
HUE053822T2 (hu) * 2012-09-20 2021-07-28 Univ Hong Kong Chinese Nem invazív módszer daganat metilom meghatározása plazmából

Also Published As

Publication number Publication date
TWI707953B (zh) 2020-10-21
JP6985753B2 (ja) 2021-12-22
IL237495B (en) 2019-09-26
HUE068129T2 (hu) 2024-12-28
NZ706269A (en) 2016-08-26
EP2898100A1 (en) 2015-07-29
ES2994426T3 (en) 2025-01-23
EP3354747B1 (en) 2021-02-17
ES2969567T3 (es) 2024-05-21
JP2022031753A (ja) 2022-02-22
IL299444B2 (en) 2024-11-01
PL2898100T5 (pl) 2023-11-06
TWI640634B (zh) 2018-11-11
JP2024009833A (ja) 2024-01-23
EP3536807B1 (en) 2023-11-29
SG10201705198UA (en) 2017-07-28
CN104781422A (zh) 2015-07-15
KR102307424B1 (ko) 2021-09-29
JP7594817B2 (ja) 2024-12-05
IL268512A (en) 2019-09-26
ES2862726T3 (es) 2021-10-07
CN104781422B (zh) 2023-12-26
IL299444A (en) 2023-02-01
EP4056712A1 (en) 2022-09-14
LT4056712T (lt) 2024-09-10
PL3536807T3 (pl) 2024-05-06
AU2013317708A1 (en) 2015-04-09
DK4056712T3 (da) 2024-08-26
HRP20241142T1 (hr) 2024-11-22
TWI806621B (zh) 2023-06-21
JP2015536639A (ja) 2015-12-24
CA2884066C (en) 2021-08-10
PL2898100T3 (pl) 2018-06-29
IL237495A0 (en) 2015-04-30
EA201500327A1 (ru) 2015-07-30
KR102148547B1 (ko) 2020-08-26
KR20230145530A (ko) 2023-10-17
HRP20240210T1 (hr) 2024-05-10
EP3536807A1 (en) 2019-09-11
IL299444B1 (en) 2024-07-01
ES2665273T3 (es) 2018-04-25
EP4335929A3 (en) 2024-05-29
LT3354747T (lt) 2021-04-12
DK3354747T3 (da) 2021-04-19
KR20150082228A (ko) 2015-07-15
SG11201501927VA (en) 2015-04-29
CA2884066A1 (en) 2014-03-27
BR112015006183A2 (pt) 2017-07-04
CN117757932A (zh) 2024-03-26
JP2025026936A (ja) 2025-02-26
AU2017251832A1 (en) 2017-11-16
BR112015006183B1 (pt) 2022-04-26
CY1124139T1 (el) 2022-05-27
PH12015500547B1 (en) 2024-05-17
PL4056712T3 (pl) 2024-12-02
EP3839065A1 (en) 2021-06-23
TW201418474A (zh) 2014-05-16
AU2022201026A1 (en) 2022-03-10
TW202305145A (zh) 2023-02-01
ES3060911T3 (en) 2026-03-30
ZA201501772B (en) 2016-10-26
PL3354747T3 (pl) 2021-07-26
NZ717423A (en) 2017-08-25
WO2014043763A1 (en) 2014-03-27
KR20210120124A (ko) 2021-10-06
EP2898100B1 (en) 2017-11-22
KR102587176B1 (ko) 2023-10-06
EP2898100B2 (en) 2023-05-10
HK1257868A1 (en) 2019-11-01
JP2018121644A (ja) 2018-08-09
AU2025205087A1 (en) 2025-07-24
EP3354747A1 (en) 2018-08-01
HK1206797A1 (en) 2016-01-15
KR20200085928A (ko) 2020-07-15
EP2898100A4 (en) 2016-05-11
CA3122779A1 (en) 2014-03-27
DK2898100T3 (en) 2018-02-26
SI4056712T1 (sl) 2024-10-30
AU2013317708C1 (en) 2017-11-23
JP6683752B2 (ja) 2020-04-22
TWI901957B (zh) 2025-10-21
EP4335929B1 (en) 2026-01-21
FI3536807T3 (fi) 2024-02-01
MX2015003571A (es) 2015-06-22
AU2013317708B2 (en) 2017-08-03
TWI784258B (zh) 2022-11-21
PH12015500547A1 (en) 2015-05-04
PT3536807T (pt) 2024-02-01
TW202043483A (zh) 2020-12-01
DK2898100T4 (da) 2023-07-24
SMT202100256T1 (it) 2021-05-07
KR102390711B1 (ko) 2022-04-26
PT4056712T (pt) 2024-08-08
FI4056712T3 (fi) 2024-08-29
EP4335929A2 (en) 2024-03-13
JP6317354B2 (ja) 2018-04-25
EP4056712B1 (en) 2024-07-31
AU2017251832B2 (en) 2019-10-10
EP4335929C0 (en) 2026-01-21
ES2665273T5 (es) 2023-10-02
EP2898100B9 (en) 2023-08-02
AU2022201026B2 (en) 2025-04-03
TW202334438A (zh) 2023-09-01
MY187444A (en) 2021-09-22
AU2020200128A1 (en) 2020-01-30
JP2020108400A (ja) 2020-07-16
HUE053822T2 (hu) 2021-07-28
PT2898100T (pt) 2018-02-26
DK3536807T3 (da) 2024-02-05
TW201907013A (zh) 2019-02-16
KR20220065034A (ko) 2022-05-19
BR122021021823B1 (pt) 2023-04-25
HRP20210716T1 (hr) 2021-06-11
BR122021021825B1 (pt) 2022-05-24
HK1207124A1 (en) 2016-01-22
MY173356A (en) 2020-01-21
PL4335929T3 (pl) 2026-04-07
IL313451A (en) 2024-08-01
PH12022552061A1 (en) 2024-03-11
PT3354747T (pt) 2021-05-07
TW202605158A (zh) 2026-02-01
HUE066054T2 (hu) 2024-07-28
AU2020200128B2 (en) 2021-11-18
IL268512B2 (en) 2023-06-01

Similar Documents

Publication Publication Date Title
CY1124139T1 (el) Μη επεμβατικος προσδιορισμος μεθυλωματος ογκου απο πλασμα
CY1118864T1 (el) Μεθοδοι και συνθεσεις για μη επεμβατικη προγεννητικη διαγνωση εμβρυϊκων ανευπλοειδιων
CY1123287T1 (el) Αναλυση γονιδιωματικων κλασματων με χρηση των αριθμων πολυμορφισμων
WO2013132305A8 (en) Size-based analysis of fetal dna fraction in maternal plasma
MX2013012167A (es) Estratificaciones a base de bcma y terapia para pacientes con mieloma multiple.
NZ745637A (en) Using cell-free dna fragment size to determine copy number variations
MX2014005800A (es) Mutaciones del receptor notch humano y su uso.
WO2012027402A3 (en) Patient-matched instruments
MX2017006670A (es) Metodos y composiciones para la modificacion genetica dirigida mediante el uso de arn guia combinados.
BR112014018331A8 (pt) Biomarcadores e terapias combinadas usando vírus oncolítico e imunomodulação
BR112015008708A2 (pt) composição para clivagem de dna alvo compreendendo um rna guia específico para o dna alvo e ácido nucleico que codifica proteína cas ou proteína cas e uso da mesma
EP3865135A3 (en) Neuroactive steroids for use in therapy
BR112015011359A2 (pt) método para indicar uma presença ou não presença de câncer de próstata agressivo
BR112017016880A2 (pt) métodos de avaliação genômica em gado
EP4234723A3 (en) Enhancement of cancer screening using cell-free viral nucleic acids
CL2017001375A1 (es) Métodos de monitoreo terapéutico de profármacos de ácido fenilacético.
WO2015198334A3 (en) Identification of cancer stem cell markers and use of same for diagnosis and treatment
CN105662567A (zh) 一种带凹槽的接骨板
MX382589B (es) Determinación no invasiva del metiloma fetal o de tumor de plasma.
WO2019103421A3 (ko) 유전자의 cpg 메틸화 변화를 이용한 간암의 예후 또는 위험도를 평가하는 방법
BR112015004279A2 (pt) processos de polimerização usando componentes de reator suspensos em géis de hidrocarboneto
JIANG et al. Genotyping of human papillomavirus in male patients with anogenital warts in Lishui area, Zhejiang province
ZHAN et al. Investigation and analysis of surgical incision infection in general surgery department
Rossi et al. In vitro effects of Plasmodium falciparum dihydrofolate reductase inhibitors on normal and cancer cell proliferation
野村綾菜 et al. The Requirements for a Design of Raspatory's Grip

Legal Events

Date Code Title Description
FG Grant or registration